查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571781

基于 CRISPR 的基因编辑市场规模、份额和趋势分析报告：按产品/服务、应用、最终用途、地区和细分市场进行预测，2024-2030 年

CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report By Product & Service (CRISPR Kits & Reagents), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

基于 CRISPR 的基因编辑市场成长与趋势：

Grand View Research, Inc.的研究报告显示，到2030年，全球基于CRISPR的基因编辑市场规模预计将达到91.4亿美元，预计2024年至2030年复合年增长率为14.73%。

该市场的强劲成长轨迹归因于遗传疾病盛行率上升、CRISPR技术的重大进步、支持性法律规范以及生物技术和医疗保健研究投资增加等几个关键因素的推动。这些因素共同创造了创新和发展的动态环境。

CRISPR 技术的进步正在显着推动市场扩张。研究人员在开发更精确、更有效率的 CRISPR 系统方面取得了重大进展，包括 CRISPR/Cas9、CRISPR/Cas12 和新的碱基编辑技术。这些创新扩大了潜在的应用范围，从治疗遗传性疾病到开发各种癌症和感染疾病的标靶治疗。具有高特异性和最小脱靶效应的基因编辑能力的增强引起了製药和生物技术领域的极大兴趣，他们希望利用这些突破性技术进行治疗开发。

此外，对个人化医疗的日益重视也对 CRISPR 技术的需求产生了重大影响。随着医疗保健转向更个人化的治疗方法，精确编辑基因的能力将使开发适合患者独特基因谱的治疗方法成为可能。这种医学模式转移可能会进一步加速 CRISPR 技术的采用。因为 CRISPR 技术提供了无与伦比的机会来开发有针对性的有效治疗方法，从而显着改善患者的治疗效果。

支持性法律规范营造有利于研究和商业化的环境。监管机构越来越认识到 CRISPR 技术的潜力，从而简化核准流程，促进创新。总体而言，这些因素的结合将为未来几年市场的持续成长和创新做好准备，为医疗保健和生物技术的革命性进步铺平道路。

基于 CRISPR 的基因编辑市场报告亮点

  • 包括CRISPR套件和试剂、CRISPR文库和其他相关工具在内的产品细分市场以2023年最高的收益占有率73.96%引领市场。
  • 从应用来看，生物医药领域预计将在 2023 年以最高的收益占有率（81.83%）引领市场，并且在预测期内的复合年增长率（CAGR）最快，达到 15.09%。这一增长是由几个关键驱动因素推动的，包括遗传疾病和癌症盛行率的增加，以及 CRISPR 技术的重大进步。
  • 按最终用途划分，製药和生物技术公司在 2023 年以 46.31% 的最高收益占有率引领市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 基于 CRISPR 的基因编辑市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望。
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 基于 CRISPR 的基因编辑市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 基于CRISPR的基因编辑市场：产品与服务的估算与趋势分析

  • 细分仪表板
  • 全球CRISPR基因编辑市场产品与服务波动分析
  • 全球基于CRISPR的基因编辑市场规模及趋势分析：依产品与服务划分，2018-2030年
  • 产品
  • 服务

第五章 基于CRISPR的基因编辑市场：应用预估与趋势分析

  • 细分仪表板
  • 全球CRISPR基因编辑市场应用变异分析
  • 2018年至2030年基于CRISPR的基因编辑全球市场规模及趋势分析：依应用分类
  • 生物医学
    • 2018年至2030年生物医学市场估计与预测
    • 治疗开发
    • 疾病诊断
  • 农业用途
    • 2018年至2030年农业应用市场估计与预测
    • 工厂工程
    • 畜牧工程
    • 其他的

第六章 基于 CRISPR 的基因编辑市场：最终用途估计与趋势分析

  • 细分仪表板
  • 全球基于 CRISPR 的基因编辑市场的最终用途变异分析
  • 2018-2030 年全球基于 CRISPR 的基因编辑市场规模和趋势分析（按最终用途）
  • 製药和生物技术公司
  • 学术研究所
  • 受託研究机构

第七章 基于CRISPR的基因编辑市场：区域估算与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018年至2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018年至2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018年至2030年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018年至2030年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 基于CRISPR的基因编辑产品和服务的主要采购商名单
  • 公司简介/名单
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Tocris Bioscience
    • OriGene Technologies, Inc.
    • Bio-Rad Laboratories
    • Bio-Techne
    • New England Biolabs, Inc.
Product Code: GVR-4-68040-468-8

CRISPR-based Gene Editing Market Growth & Trends:

The global CRISPR-based gene editing market size is anticipated to reach USD 9.14 billion by 2030 and is projected to grow at a CAGR of 14.73% from 2024 to 2030, according to a report by Grand View Research, Inc. This robust growth trajectory in the market is driven by several key factors, including the rising prevalence of genetic disorders, significant advancements in CRISPR technology, supportive regulatory frameworks, and increasing investments in biotechnology and healthcare research. Together, these elements create a dynamic environment for innovation and development.

Advancements in CRISPR technology have notably fueled market expansion. Researchers have made remarkable progress in developing more precise and efficient CRISPR systems, including CRISPR/Cas9, CRISPR/Cas12, and emerging base editing technologies. These innovations have broadened the scope of potential applications, extending from treating genetic disorders to formulating targeted therapies for various cancers and infectious diseases. The enhanced ability to edit genes with high specificity and minimal off-target effects has captured considerable interest from both pharmaceutical and biotechnology sectors, which are increasingly eager to leverage these groundbreaking technologies for therapeutic development.

Moreover, the growing emphasis on personalized medicine is significantly influencing the demand for CRISPR technologies. As the healthcare landscape shifts toward more individualized treatment approaches, the capability to edit genes with precision enables the creation of therapies tailored to the unique genetic profiles of patients. This paradigm shift in medicine is likely to further accelerate the adoption of CRISPR technologies, as they provide unparalleled opportunities to develop targeted and effective treatments that can dramatically improve patient outcomes.

Supportive regulatory frameworks are fostering a conducive environment for research and commercialization. Regulatory bodies are increasingly recognizing the potential of CRISPR technologies, leading to streamlined approval processes that encourage innovation. Overall, the confluence of these factors positions the market for continued growth and innovation in the coming years, paving the way for revolutionary advancements in healthcare and biotechnology.

CRISPR-based Gene Editing Market Report Highlights:

  • The products segment, which includes CRISPR kits and reagents, CRISPR libraries, and other related tools, led the market with the largest revenue share of 73.96% in 2023
  • Based on application, the biomedical segment led the market with the largest revenue share of 81.83% in 2023 and is also projected to witness at the fastest CAGR of 15.09% during the forecast period. This growth is fueled by several key drivers, including the increasing prevalence of genetic disorders and cancers, alongside significant advancements in CRISPR technology
  • Based on end use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 46.31% in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of genetic disorders
      • 3.2.1.2. Growing investments in biotechnology and healthcare research
      • 3.2.1.3. Advancements in CRISPR technology and applications
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Ethical concerns surrounding gene editing
      • 3.2.2.2. High costs associated with CRISPR research and development
  • 3.3. CRISPR-based Gene Editing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
  • 4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. CRISPR Kits & Reagents
      • 4.4.2.1. CRISPR kits & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. CRISPR Libraries
      • 4.4.3.1. CRISPR libraries market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
  • 5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biomedical
    • 5.4.1. Biomedical market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Therapeutic Development
      • 5.4.2.1. Therapeutic development market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.2. By Indication
        • 5.4.2.2.1. Genetic Disorders
          • 5.4.2.2.1.1. Genetic Disorders market estimates and forecasts, 2018 to 2030 (USD Million)
        • 5.4.2.2.2. Oncology
          • 5.4.2.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
        • 5.4.2.2.3. Ophthalmology
          • 5.4.2.2.3.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
        • 5.4.2.2.4. Others
          • 5.4.2.2.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.3. By Delivery Method
        • 5.4.2.3.1. Ex Vivo
        • 5.4.2.3.2. Ex vivo market estimates and forecasts, 2018 to 2030 (USD Million
        • 5.4.2.3.3. In Vivo
        • 5.4.2.3.4. In vivo market estimates and forecasts, 2018 to 2030 (USD Million
    • 5.4.3. Disease Diagnostics
      • 5.4.3.1. Disease diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Agricultural applications
    • 5.5.1. Agricultural applications market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.2. Plant Engineering
      • 5.5.2.1. Plant engineering market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.3. Farm Animals Engineering
      • 5.5.3.1. Farm animals engineering market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. CRISPR-based Gene Editing Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global CRISPR-based Gene Editing Market End-use Movement Analysis
  • 6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract research organizations market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Target disease prevalence
      • 7.4.2.4. Regulatory framework
      • 7.4.2.5. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Target disease prevalence
      • 7.4.3.4. Regulatory framework
      • 7.4.3.5. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Target disease prevalence
      • 7.4.4.4. Regulatory framework
      • 7.4.4.5. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Target disease prevalence
      • 7.5.2.4. Regulatory framework
      • 7.5.2.5. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Target disease prevalence
      • 7.5.3.4. Regulatory framework
      • 7.5.3.5. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Target disease prevalence
      • 7.5.4.4. Regulatory framework
      • 7.5.4.5. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Target disease prevalence
      • 7.5.5.4. Regulatory framework
      • 7.5.5.5. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Target disease prevalence
      • 7.5.6.4. Regulatory framework
      • 7.5.6.5. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Target disease prevalence
      • 7.5.7.4. Regulatory framework
      • 7.5.7.5. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Target disease prevalence
      • 7.5.8.4. Regulatory framework
      • 7.5.8.5. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Target disease prevalence
      • 7.5.9.4. Regulatory framework
      • 7.5.9.5. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Target disease prevalence
      • 7.6.2.4. Regulatory framework
      • 7.6.2.5. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Target disease prevalence
      • 7.6.3.4. Regulatory framework
      • 7.6.3.5. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Target disease prevalence
      • 7.6.4.4. Regulatory framework
      • 7.6.4.5. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Target disease prevalence
      • 7.6.5.4. Regulatory framework
      • 7.6.5.5. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Target disease prevalence
      • 7.6.6.4. Regulatory framework
      • 7.6.6.5. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Target disease prevalence
      • 7.6.7.4. Regulatory framework
      • 7.6.7.5. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Target disease prevalence
      • 7.7.2.4. Regulatory framework
      • 7.7.2.5. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Target disease prevalence
      • 7.7.3.4. Regulatory framework
      • 7.7.3.5. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Target disease prevalence
      • 7.8.2.4. Regulatory framework
      • 7.8.2.5. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Target disease prevalence
      • 7.8.3.4. Regulatory framework
      • 7.8.3.5. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Target disease prevalence
      • 7.8.4.4. Regulatory framework
      • 7.8.4.5. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Target disease prevalence
      • 7.8.5.4. Regulatory framework
      • 7.8.5.5. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. List of Key Buyers for CRISPR-based Gene Editing Products & Services
  • 8.5. Company Profiles/Listing
    • 8.5.1. Revvity, Inc.
      • 8.5.1.1. Company overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product/Service benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Danaher Corporation
      • 8.5.2.1. Company overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product/Service benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. GenScript
      • 8.5.3.1. Company overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product/Service benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Merck KGaA
      • 8.5.4.1. Company overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product/Service benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Thermo Fisher Scientific, Inc.
      • 8.5.5.1. Company overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product/Service benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Tocris Bioscience
      • 8.5.6.1. Company overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product/Service benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. OriGene Technologies, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product/Service benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Bio-Rad Laboratories
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product/Service benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Bio-Techne
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product/Service benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. New England Biolabs, Inc.
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product/Service benchmarking
      • 8.5.10.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviation
  • Table 2. Global CRISPR-based gene editing market, by region, 2018 - 2030 (USD Million)
  • Table 3. Global CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4. Global CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 5. Global CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 6. North America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 8. North America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 9. North America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 10. U.S. CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 11. U.S. CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 12. U.S. CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 13. Canada CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 14. Canada CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 15. Canada CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. Mexico CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 17. Mexico CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 18. Mexico CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Europe CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 21. Europe CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 22. Europe CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 23. UK CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 24. UK CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 25. UK CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 26. Germany CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 27. Germany CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 28. Germany CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29. France CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 30. France CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 31. France CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 32. Italy CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 33. Italy CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 34. Italy CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 35. Spain CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 36. Spain CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 37. Spain CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 38. Denmark CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 39. Denmark CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 40. Denmark CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 41. Sweden CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 42. Sweden CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 43. Sweden CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44. Norway CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 45. Norway CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 46. Norway CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 51. Japan CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 52. Japan CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 53. Japan CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54. China CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 55. China CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 56. China CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 57. India CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 58. India CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 59. India CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 60. Australia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 61. Australia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 62. Australia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 63. South Korea CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 64. South Korea CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 65. South Korea CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 66. Thailand CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 67. Thailand CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 68. Thailand CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Latin America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 70. Latin America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 71. Latin America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 72. Latin America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 73. Brazil CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 74. Brazil CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 75. Brazil CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 76. Argentina CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 77. Argentina CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 78. Argentina CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 79. MEA CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 80. MEA CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 81. MEA CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 82. MEA CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 83. South Africa CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 84. South Africa CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 85. South Africa CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 89. UAE CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 90. UAE CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 91. UAE CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 92. Kuwait CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 93. Kuwait CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 94. Kuwait CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 CRISPR-based Gene Editing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 CRISPR-based Gene editing market: Product & service outlook key takeaways
  • Fig. 20 CRISPR-based Gene editing market: Product & service movement analysis
  • Fig. 21 Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 CRISPR kits & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 CRISPR libraries market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 CRISPR-based gene editing market: Application outlook key takeaways
  • Fig. 27 CRISPR-based gene editing market: Application movement analysis
  • Fig. 28 Biomedical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Therapeutic development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Genetic disorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Ophthalmology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Ex vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 In vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Agricultural applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Plant engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Farm animals engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 CRISPR-based gene editing market: End use outlook key takeaways
  • Fig. 42 CRISPR-based gene editing market: End use movement analysis
  • Fig. 43 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Academic & research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Regional marketplace outlook, 2023 & 2030 (USD Million)
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 US CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Canada CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Mexico CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Europe CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Germany CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 France CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Denmark CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Korea CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 UAE CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Kuwait CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Market participant categorization
  • Fig. 98 Company market position analysis, 2023
  • Fig. 99 Strategic framework